UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): October 31, 2006


                       WHISPERING OAKS INTERNATIONAL, INC.
                       -----------------------------------
             (Exact name of registrant as specified in its charter)

                    Texas                           75-2742601
        -------------------                  --------------------------
         (State of incorporation)        (I.R.S. Employer Identification Number)


                           7080 River Road, Suite 215
                   Richmond, British Columbia, Canada V6X 1X5
               --------------------------------------------------
              (address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:    (604) 207-9150
                                                       --------------

                                       N/A
                 ----------------------------------------- ----
          (Former name or former address if changed since last report)


Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))



<PAGE>


Item 7.01   Regulation FD Disclosure


      The Company will appear on the broadcast television show Your Cancer
Today. The scheduled date is the weekend of November 4 and 5, 2006.

      During the interview, the Company will discuss its RECAF technology which
allows for the detection of the majority of cancers with a basic blood test;
along with the potential use of RECAF for imaging the location of the cancer and
for cancer therapy. The interview will focus on the importance of cancer
diagnosis using a simple inexpensive blood test as it pertains to reducing
overall medical costs, with an emphasis on the individual patient that will
benefit by the early stage cancer detection or by monitoring for any recurrence
of a treated cancer. The Company's RECAF technology has the potential to
dramatically enhance medical care through early cancer detection of all the
major cancers including cancer of the prostate, breast, lung, colon, stomach,
ovaries and others.

      Your Cancer Today is television show with related internet web site. The
show explores cancer diagnosis and treatment and current research breakthroughs
with expert commentators. The show is intended to inform and educate viewers
with source notations allowing further investigation. A list of the broadcast
coverage areas, show times and broadcasting stations can be found at their web
site - Your Cancer Today.









<PAGE>


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Date:  October 31, 2006

                                     WHISPERING OAKS INTERNATIONAL, INC.



                                     By:  /s/ Dr. Ricardo Moro
                                          ------------------------------------
                                          Dr. Ricardo Moro, President
[{"type": "8-K", "sequence": "1", "filename": "oct06form8k.txt", "secsgml_size_bytes": 3983}]
{"company-data": {"conformed-name": "WHISPERING OAKS INTERNATIONAL INC", "cik": "0001092562", "assigned-sic": "3841", "irs-number": "752742601", "state-of-incorporation": "A1", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26947", "film-number": "061177558"}, "business-address": {"street1": "7080 RIVER RD", "street2": "STE 215", "city": "RICHMOND", "state": "A1", "zip": "V6X 1X5", "phone": "6042079150"}, "mail-address": {"street1": "7080 RIVER RD", "street2": "STE 215", "city": "RICHMOND", "state": "A1", "zip": "V6X 1X5"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): October 31, 2006

                       WHISPERING OAKS INTERNATIONAL, INC.
                       -----------------------------------
             (Exact name of registrant as specified in its charter)

                    Texas                           75-2742601
        -------------------                  --------------------------
         (State of incorporation)        (I.R.S. Employer Identification Number)

                           7080 River Road, Suite 215
                   Richmond, British Columbia, Canada V6X 1X5
               --------------------------------------------------
              (address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:    (604) 207-9150
                                                       --------------

                                       N/A
                 ----------------------------------------- ----
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))
Item 7.01   Regulation FD Disclosure

      The Company will appear on the broadcast television show Your Cancer
Today. The scheduled date is the weekend of November 4 and 5, 2006.

      During the interview, the Company will discuss its RECAF technology which
allows for the detection of the majority of cancers with a basic blood test;
along with the potential use of RECAF for imaging the location of the cancer and
for cancer therapy. The interview will focus on the importance of cancer
diagnosis using a simple inexpensive blood test as it pertains to reducing
overall medical costs, with an emphasis on the individual patient that will
benefit by the early stage cancer detection or by monitoring for any recurrence
of a treated cancer. The Company's RECAF technology has the potential to
dramatically enhance medical care through early cancer detection of all the
major cancers including cancer of the prostate, breast, lung, colon, stomach,
ovaries and others.

      Your Cancer Today is television show with related internet web site. The
show explores cancer diagnosis and treatment and current research breakthroughs
with expert commentators. The show is intended to inform and educate viewers
with source notations allowing further investigation. A list of the broadcast
coverage areas, show times and broadcasting stations can be found at their web
site - Your Cancer Today.
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  October 31, 2006

                                     WHISPERING OAKS INTERNATIONAL, INC.

                                     By:  /s/ Dr. Ricardo Moro
                                          ------------------------------------
                                          Dr. Ricardo Moro, President